| Year |
Title |
Altmetric |
| 2020
|
Racial disparities and factors associated with prescription for smoking cessation medications among smokers receiving routine clinical care for HIV
2020
|
|
| 2020
|
Prior incarceration associated with missed HIV care visits among young people living with HIV in the US
2020
|
|
| 2020
|
Transmission Risk Among Youth Living With HIV in the U.S..
Journal of Adolescent Health.
67:61-68.
2020
|
|
| 2020
|
Changes in Bone Mass after Discontinuation of Preexposure Prophylaxis with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex with Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.
Clinical Infectious Diseases.
70:687-691.
2020
|
|
| 2020
|
Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women
2020
|
|
| 2019
|
Predictors of smoking cessation among people living with HIV receiving routine clinical care
2019
|
|
| 2019
|
Mental health disorders and alcohol use are associated with increased likelihood of smoking relapse among people living with HIV attending routine clinical care.
BMC Public Health.
19.
2019
|
|
| 2019
|
Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.
Papillomavirus Research.
7:52-61.
2019
|
|
| 2019
|
A measure to assess HIV treatment readiness among adolescents and young adults.
Vulnerable Children and Youth Studies.
14:142-150.
2019
|
|
| 2019
|
Role of sociobehavioral factors in subprotective TFV-DP Levels among YMSM Enrolled in 2 PrEP Trials
2019
|
|
| 2019
|
Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.
AIDS Research and Human Retroviruses.
35:123-128.
2019
|
|
| 2018
|
Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum
2018
|
|
| 2018
|
Correlates of Serodiscordant Condomless Anal Intercourse Among Virologically Detectable HIV-Positive Young Men Who Have Sex with Men.
AIDS and Behavior.
22:3535-3539.
2018
|
|
| 2018
|
A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.
Sexually Transmitted Infections.
94:304-308.
2018
|
|
| 2018
|
HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination.
AIDS and Behavior.
22:1826-1834.
2018
|
|
| 2018
|
Tobacco Use and Sustained Viral Suppression in Youth Living with HIV.
AIDS and Behavior.
22:2018-2025.
2018
|
|
| 2018
|
In reply.
JAMA Pediatrics.
172:391-392.
2018
|
|
| 2018
|
Linking HIV-Negative Youth to Prevention Services in 12 U.S. Cities: Barriers and Facilitators to Implementing the HIV Prevention Continuum.
Journal of Adolescent Health.
62:424-433.
2018
|
|
| 2018
|
Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United States.
Clinical Infectious Diseases.
66:213-219.
2018
|
|
| 2018
|
Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults with Human Immunodeficiency Virus Infection Being Treated with Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.
Clinical Infectious Diseases.
66:220-228.
2018
|
|
| 2018
|
HIV Continuum of Care for Youth in the United States
2018
|
|
| 2018
|
Partner Notification for Youth Living With HIV in 14 Cities in the United States
2018
|
|
| 2018
|
Tenofovir disoproxil fumarate appears to disrupt the relationship of Vitamin D and parathyroid hormone.
Antiviral Therapy.
23:623-6928.
2018
|
|
| 2017
|
Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States.
JAMA Pediatrics.
171:1063-1071.
2017
|
|
| 2017
|
Implementation of an integrated approach to the national HIV/AIDS strategy for improving human immunodeficiency virus care for youths.
JAMA Pediatrics.
171:687-693.
2017
|
|
| 2017
|
Strengthening and expanding the capacity of health worker education in Zambia.
Pan African Medical Journal.
27.
2017
|
|
| 2017
|
Evaluating testing strategies for identifying youths with HIV infection and linking youths to biomedical and other prevention services.
JAMA Pediatrics.
171:532-537.
2017
|
|
| 2017
|
An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM
2017
|
|
| 2017
|
Decline in bone mass with tenofovir disoproxil fumarate/emtricitabine is associated with hormonal changes in the absence of renal impairment when used by HIV-uninfected adolescent boys and young men for HIV preexposure prophylaxis.
Clinical Infectious Diseases.
64:317-325.
2017
|
|
| 2016
|
Emtricitabine-Triphosphate in dried blood spots as a marker of recent dosing.
Antimicrobial Agents and Chemotherapy.
60:6692-6697.
2016
|
|
| 2016
|
Preventing HIV among adolescents with oral PrEP: Observations and challenges in the United States and South Africa.
Journal of the International AIDS Society.
19.
2016
|
|
| 2016
|
Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.
Journal of NeuroVirology.
22:218-230.
2016
|
|
| 2016
|
Sexual risk behavior among virologically detectable human immunodeficiency virus-infected young men who have sex with men.
JAMA Pediatrics.
170:125-131.
2016
|
|
| 2015
|
Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care..
Journal of AIDS and Clinical Research.
6.
2015
|
|
| 2015
|
Immune reconstitution but persistent activation after 48 weeks of antiretroviral therapy in youth with pre-therapy CD4 >350 in ATN 061
2015
|
|
| 2015
|
How we implemented an analytical support clinic to strengthen student research capacity in Zambia.
Medical Teacher.
37:635-640.
2015
|
|
| 2015
|
Mitochondrial DNA diversity in the African American population
2015
|
|
| 2015
|
Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States
2015
|
|
| 2014
|
Mitochondrial DNA variation and virologic and immunological HIV outcomes in African Americans.
AIDS.
28:1871-1878.
2014
|
|
| 2014
|
KIR2DS4 promotes HIV-1 pathogenesis: New evidence from analyses of immunogenetic data and natural killer cell function.
PLoS ONE.
9.
2014
|
|
| 2014
|
How we implemented an analytic support clinic to strengthen student research capacity in Zambia.
Medical Teacher.
1:1-6.
2014
|
|
| 2014
|
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.
Antiviral Therapy.
19:613-618.
2014
|
|
| 2013
|
Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: Fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein.
Frontiers in Genetics.
4.
2013
|
|
| 2013
|
Oral Lesions: Poor Markers of Virologic Failure in HIV-Infected Patients on Antiretroviral Therapy.
ISRN Infectious Diseases.
2013:1-7.
2013
|
|
| 2013
|
Association of higher plasma vitamin d binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: Cause of a functional Vitamin D deficiency?.
Antimicrobial Agents and Chemotherapy.
57:5619-5628.
2013
|
|
| 2013
|
Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.
Human Immunology.
74:1696-1700.
2013
|
|
| 2013
|
Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.
Clinical Infectious Diseases.
57:735-744.
2013
|
|
| 2013
|
Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States.
Sexually Transmitted Diseases.
40:715-720.
2013
|
|
| 2013
|
Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA.
International Journal of STD and AIDS.
24:123-127.
2013
|
|
| 2013
|
Body condition scoring for Laboratory Zebrafish.
Animal Technology and Welfare.
12:1-7.
2013
|
|
| 2013
|
The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men
2013
|
|
| 2013
|
Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: Role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.
AIDS Research and Human Retroviruses.
29:493-500.
2013
|
|
| 2013
|
Comprehension of a simplified assent form in a vaccine trial for adolescents.
Journal of Medical Ethics.
39:410-412.
2013
|
|
| 2012
|
Aspects of larval rearing
2012
|
|
| 2012
|
Prevalence of proteinuria and elevated serum cystatin c among hiv-infected adolescents in the reaching for Excellence in Adolescent Care and Health (REACH) study
2012
|
|
| 2012
|
Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents.
Journal of Reproductive Immunology.
96:84-89.
2012
|
|
| 2012
|
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.
Journal of Clinical Endocrinology and Metabolism.
97:4004-4013.
2012
|
|
| 2012
|
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent trials network study 021B.
Clinical Infectious Diseases.
55:461-468.
2012
|
|
| 2012
|
Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents.
Sexually Transmitted Diseases.
39:300-305.
2012
|
|
| 2012
|
Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.
AIDS Patient Care and STDS.
26:193-196.
2012
|
|
| 2012
|
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: A randomized, placebo-controlled trial.
Clinical Infectious Diseases.
54:1013-1025.
2012
|
|
| 2012
|
Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.
PLoS ONE.
7.
2012
|
|
| 2012
|
Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.
2012
|
|
| 2011
|
Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a southeastern US clinic.
Journal of Public Health Dentistry.
71:257-264.
2011
|
|
| 2011
|
Prevalence, incidence, and recurrence of oral lesions among HIV-infected patients on HAART in Alabama: A two-year longitudinal study.
Southern Medical Journal.
104:561-566.
2011
|
|
| 2011
|
Sex ratio bias and embryo production in Zebrafish housed in 10 litre aquaria.
Animal Technology and Welfare.
10:146-147.
2011
|
|
| 2011
|
Identification of three immunologic correlates for HIV type 1 pathogenesis in Youth.
AIDS Research and Human Retroviruses.
27:639-646.
2011
|
|
| 2011
|
Hepatitis B vaccination in HIV-infected youth: A randomized trial of three regimens
2011
|
|
| 2011
|
The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.
Human Immunology.
72:312-318.
2011
|
|
| 2011
|
Hormonal contraceptive use and response to antiretroviral therapy among adolescent females.
HIV and AIDS Review.
10:65-69.
2011
|
|
| 2011
|
The Zambian HIV Nurse practitioner diploma program: Preliminary outcomes from first cohort of Zambian Nurses.
International Journal of Nursing Education Scholarship.
8.
2011
|
|
| 2010
|
Interleukin-10 (IL-10) pathway: Genetic variants and outcomes of HIV-1 infection in African American adolescents.
PLoS ONE.
5.
2010
|
|
| 2010
|
Association between Anemia and Aflatoxin B-1 Biomarker Levels among Pregnant Women in Kumasi, Ghana.
American Journal of Tropical Medicine and Hygiene.
83:1077-1083.
2010
|
|
| 2010
|
The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.
BMC Infectious Diseases.
10.
2010
|
|
| 2010
|
Epidemiology of HIV infection and risk in adolescents and youth
2010
|
|
| 2010
|
Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.
Journal of Virology.
84:2610-2617.
2010
|
|
| 2010
|
Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana.
Tropical Medicine and International Health.
15:160-167.
2010
|
|
| 2010
|
Demographic Profiles of Newly Acquired HIV Infections Among Adolescents and Young Adults in the U.S..
Journal of Adolescent Health.
46:93-96.
2010
|
|
| 2010
|
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent trials network study 021.
Clinical Infectious Diseases.
50:106-114.
2010
|
|
| 2010
|
Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy Urban adolescents in the United States
2010
|
|
| 2009
|
Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: Analyses of the Reaching for Excellence in Adolescent Care and Health (REACH) Project.
JAMA Pediatrics.
163:1100-1105.
2009
|
|
| 2009
|
Clear and independent associations of several HLA-DRB1 alleles with diVerential antibody responses to hepatitis B vaccination in youth.
Human Genetics.
126:685-696.
2009
|
|
| 2009
|
Short-cycle therapy in adolescents after continuous therapy with established viral suppression: The impact on viral load suppression.
AIDS Research and Human Retroviruses.
25:555-561.
2009
|
|
| 2009
|
Host genetics and HIV-1 viral load set-point in African-Americans.
AIDS.
23:673-677.
2009
|
|
| 2008
|
Immunogenetic correlates of neisseria gonorrhoeae infection in adolescents.
Sexually Transmitted Diseases.
35:656-661.
2008
|
|
| 2008
|
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.
Antimicrobial Agents and Chemotherapy.
52:631-637.
2008
|
|
| 2008
|
Inclusion of adolescents in preventive HIV vaccine trials: Public health policy and research design at a crossroads
2008
|
|
| 2007
|
Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
AIDS.
21:2387-2397.
2007
|
|
| 2007
|
Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia
2007
|
|
| 2007
|
HIV voluntary counseling and testing among injection drug users in south China: A study of a non-government organization based program.
AIDS and Behavior.
11:778-788.
2007
|
|
| 2007
|
Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.
Cancer Epidemiology, Biomarkers and Prevention.
16:1626-1632.
2007
|
|
| 2007
|
Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections.
Journal of Clinical Laboratory Analysis.
21:40-45.
2007
|
|
| 2007
|
CCL3L1 and CCL4L1: Variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.
Genes and Immunity.
8:224-231.
2007
|
|
| 2007
|
Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults.
American Journal of Clinical Nutrition.
85:173-181.
2007
|
|
| 2006
|
Prevalence of primary HIV-1 drug resistance among recently infected adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study.
Journal of Infectious Diseases.
194:1505-1509.
2006
|
|
| 2006
|
Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression.
AIDS.
20:1583-1590.
2006
|
|
| 2006
|
HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.
Journal of Immunology.
176:6130-6146.
2006
|
|
| 2006
|
Vitamin D status in adolescents and young adults with HIV infection.
American Journal of Clinical Nutrition.
83:1135-1141.
2006
|
|
| 2006
|
Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults.
Clinical and Experimental Immunology.
144:117-124.
2006
|
|
| 2006
|
Vitamins C and E in adolescents and young adults with HIV infection.
American Journal of Clinical Nutrition.
83:870-879.
2006
|
|
| 2006
|
Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: Week 60 results from the PACTG 381 cohort.
AIDS Research and Human Retroviruses.
22:213-221.
2006
|
|
| 2006
|
Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients.
AIDS.
20:353-360.
2006
|
|
| 2005
|
Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents.
Clinical and Experimental Immunology.
142:548-554.
2005
|
|
| 2005
|
Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.
JAMA Pediatrics.
159:764-770.
2005
|
|
| 2005
|
Plasma cytokines and oxidative damage in HIV-positive and HIV-negative adolescents and young adults: A protective role for IL-10?.
Free Radical Research.
39:859-864.
2005
|
|
| 2005
|
Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents.
Journal of Infectious Diseases.
191:1084-1092.
2005
|
|
| 2005
|
CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.
AIDS.
19:241-250.
2005
|
|
| 2005
|
Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents
2005
|
|
| 2004
|
Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents.
Journal of Infectious Diseases.
190:1723-1729.
2004
|
|
| 2004
|
HIV-infected US youth are at high risk of obesity and poor diet quality: A challenge for improving short- and long-term health outcomes.
Journal of The American Dietetic Association.
104:1554-1560.
2004
|
|
| 2004
|
US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function.
Journal of The American Dietetic Association.
104:1095-1101.
2004
|
|
| 2004
|
Cytokine and Chemokine Gene Polymorphisms among Ethnically Diverse North Americans with HIV-1 Infection
2004
|
|
| 2004
|
HLA and Cytokine Gene Polymorphisms Are independently Associated with Responses to Hepatitis B Vaccination.
Hepatology.
39:978-988.
2004
|
|
| 2004
|
CD8+CD88+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV + adolescent population.
AIDS Research and Human Retroviruses.
20:263-269.
2004
|
|
| 2004
|
Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025
2004
|
|
| 2004
|
Erratum: CD8+ CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ cell loss in a predominantly minority female HIV+ adolescent population (AIDS Research and Human Retroviruses (2004) 22 (263-269)).
AIDS Research and Human Retroviruses.
20:575.
2004
|
|
| 2003
|
T Cell Responses in HIV Type 1-Infected Adolescent Minorities Share Similar Epitope Specificities with Whites Despite Significant Differences in HLA Class I Alleles.
AIDS Research and Human Retroviruses.
19:1017-1026.
2003
|
|
| 2003
|
Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities
2003
|
|
| 2003
|
CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.
AIDS Research and Human Retroviruses.
19:487-495.
2003
|
|
| 2003
|
TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths
2003
|
|
| 2003
|
Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection
2003
|
|
| 2003
|
The relationships between substance abuse, psychosocial variables, and natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents.
AIDS Research and Human Retroviruses.
19:399-408.
2003
|
|
| 2003
|
Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles
2003
|
|
| 2003
|
Barriers to HAART adherence among human immunodeficiency virus - Infected adolescents.
JAMA Pediatrics.
157:249-255.
2003
|
|
| 2003
|
Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents.
AIDS.
17:311-320.
2003
|
|
| 2002
|
Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.
AIDS Research and Human Retroviruses.
18:1301-1310.
2002
|
|
| 2002
|
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents.
AIDS.
16:2275-2284.
2002
|
|
| 2002
|
Barriers to HIV testing - Where next?
2002
|
|
| 2002
|
Peripheral blood lymphocyte subsets in adolescents: A longitudinal analysis from the REACH project
2002
|
|
| 2002
|
CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: Limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy.
AIDS Research and Human Retroviruses.
18:403-412.
2002
|
|
| 2001
|
HIV-related oral manifestations among adolescents in a multicenter cohort study.
Journal of Adolescent Health.
29:109-114.
2001
|
|
| 2001
|
Douching practices among HIV infected and uninfected adolescents in the United States.
Journal of Adolescent Health.
29:80-86.
2001
|
|
| 2001
|
Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort.
Journal of Adolescent Health.
29:123-129.
2001
|
|
| 2001
|
Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study.
Journal of Adolescent Health.
29:49-56.
2001
|
|
| 2001
|
The REACH (Reaching for Excellence in Adolescent Care and Health) project: Study design, methods, and population profile.
Journal of Adolescent Health.
29:8-18.
2001
|
|
| 2001
|
Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus
2001
|
|
| 2001
|
Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA
2001
|
|
| 2001
|
Natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents.
AIDS Research and Human Retroviruses.
17:543-552.
2001
|
|
| 2000
|
Marijuana use among HIV-positive and high-risk adolescents: A comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis.
American Journal of Epidemiology.
152:805-813.
2000
|
|
| 2000
|
Erratum: T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: Retention of naive T lymphocytes in HIV-infected adolescents (Archives (2000) 154 (375-380)).
JAMA Pediatrics.
154:911.
2000
|
|
| 2000
|
Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents.
AIDS Research and Human Retroviruses.
16:959-963.
2000
|
|
| 2000
|
Pinworm (Enterobius vermicularis).
Seminars in Pediatric Infectious Diseases.
11:252-256.
2000
|
|
| 2000
|
Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: Impact of infection with human immunodeficiency virus.
JAMA Pediatrics.
154:127-134.
2000
|
|
| 2000
|
Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: Findings of the reach study.
Sexually Transmitted Diseases.
27:296-303.
2000
|
|
| 2000
|
T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: Retention of naive T lymphocytes in HIV-infected adolescents.
JAMA Pediatrics.
154:375-380.
2000
|
|
| 2000
|
The prevalence of anergy in Human Immunodeficiency Virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics.
Journal of Adolescent Health.
27:384-390.
2000
|
|
| 1999
|
The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression.
Journal of Biological Chemistry.
274:35255-35261.
1999
|
|
| 1999
|
Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus.
Molecular and Biochemical Parasitology.
103:1-14.
1999
|
|
| 1999
|
Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents.
AIDS.
13:1629-1635.
1999
|
|
| 1998
|
The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, methods, and selected characteristics of participants.
Journal of Adolescent Health.
22:300-311.
1998
|
|
| 1997
|
Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum
1997
|
|
| 1996
|
Characterization of the δ-aminolevulinate synthase gene homologue in P. falciparum.
Molecular and Biochemical Parasitology.
75:271-275.
1996
|
|
| 1996
|
Erratum: Characterization of the δ-aminolevulinate synthase gene homologue in P. falciparum (Molecular and Biochemical Parasitology 75 (1996) (271-276)).
Molecular and Biochemical Parasitology.
79:135-140.
1996
|
|
| 1996
|
Molecular characterization of airport malaria.
Journal of Travel Medicine.
3:179-181.
1996
|
|
| 1996
|
Plasmodium falciparum: Molecular characterization of multidrug-resistant Cambodian isolates.
Experimental Parasitology.
82:97-103.
1996
|
|
| 1995
|
Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Subsaharan Africa.
Molecular and Biochemical Parasitology.
74:157-166.
1995
|
|
| 1995
|
Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum.
Molecular and Biochemical Parasitology.
69:135-138.
1995
|
|
| 1994
|
Characterization of the pfmdr2 gene for Plasmodium falciparum.
Molecular and Biochemical Parasitology.
63:311.
1994
|
|
| 1994
|
Respiratory distress caused by parasites.
1994
|
|
| 1993
|
Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen
1993
|
|
| 1993
|
Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.
Molecular and Biochemical Parasitology.
57:151-160.
1993
|
|
| 1993
|
Characterization of the pfmdr 2 gene for Plasmodium falciparum.
Molecular and Biochemical Parasitology.
62:83-92.
1993
|
|
| 1993
|
Stage-specific transcripts of the Plasmodium falciparum pfmdr1 gene.
Molecular and Biochemical Parasitology.
57:203-211.
1993
|
|
| 1993
|
The dihydroorotate dehydrogenase gene homologue of Plasmodium falciparum.
Molecular and Biochemical Parasitology.
60:349-351.
1993
|
|
| 1991
|
Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia.
Bone Marrow Transplantation.
8:143-145.
1991
|
|
| 1990
|
Scedosporium inflatum: Clinical spectrum of a newly recognized pathogen.
Journal of Infectious Diseases.
161:102-107.
1990
|
|
| 1989
|
A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery
1989
|
|
| 1989
|
Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum.
Science.
244:1184-1186.
1989
|
|
| 1987
|
A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection.
Critical Care Medicine.
15:1051-1054.
1987
|
|
